Volume demand accelerated slightly in 2020 as a result of the reaction to the lockdown, with many consumers being anxious to ensure a steady supply. A lot of prescribers are elderly people needing to self-isolate more than others given the lower immunity among the elderly if contracting the virus.
Although taking care of the adult incontinence condition is considered crucial in preserving dignity and quality of life, remedying products were still not included in the Colombian Health Benefits Plan (PBS). It is believed to be only a matter of time, however, before they are covered by the Plan and therefore healthcare companies (EPSs) will need to provide these items upon receipt of a health practitioner’s prescription.
COVID-19 had only a limited impact on Rx/reimbursement adult incontinence, with the channel’s supply being regulated by healthcare providers, which are less vulnerable to demand surplus than retailers. Demand is expected to return to normal in 2021 and going forward, following the pressures of 2020 and redirection of medical care.
As previously mentioned, adult incontinence products are still outside of the Health Benefits Plan, which contains the list of technologies, supplies and medicines that are provided by the healthcare system against a medical prescription. The reimbursement of adult incontinence is covered by FOSYGA (Fondo de Solidaridad y Garantía), a fund created by Law 100 of 1993, which is the basis of the current healthcare system in Colombia and dedicated to cover catastrophic health or personal events and traffic accidents.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Colombia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Colombia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page